To Whom it
May Concern
Re: Witness report for Susan
Oliver – Nurse Prescribing Course Spring 2006.
The National Patient Safety
Agency (NPSA) safety alert on Methotrexate was issued in July 2004. Following the publication, The British
Society for Rheumatology (BSR), British Association of Dermatologists (BAD) and
British Society for Gastroenterologists (BSG) worked with the NPSA to review
and refine clinical information and information for patients contained within
two Methotrexate documents intended for issue to patients or their carers.
Susan Oliver was initially
commissioned by the BSR to project manage this work which included collating
responses from professional and patient groups, review clinical research evidence
and write draft submissions in relation to Methotrexate.
When the project with the
BSR was complete the NPSA further commissioned Susan to complete some
additional work (also related to Methotrexate).
The work required an
in-depth understanding of the pharmacology of Methotrexate, prescribing and
governance issues as well as practical issues related to daily clinical
practice and ensuring safe high quality patient care.
The work was completed in a
professional manner, was clinically accurate, and utilised language which is
easily assimilated by patients and carers.
Susan’s ability to
understand the medication in question, review the clinical and research
evidence, critically appraise and produce a report acceptable to a wide range
of stakeholders is to be commended.
Yours sincerely
Wendy Harris
Head of Safety Solutions